Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion InjuryPodsawee Mongkolpathumrat, Sarawut Kumphune|Biomedicines|2021Cited by 14